These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10103216)

  • 1. Effect of 3-hydroxyphthaloyl-beta-lactoglobulin on vaginal transmission of simian immunodeficiency virus in rhesus monkeys.
    Wyand MS; Manson KH; Miller CJ; Neurath AR
    Antimicrob Agents Chemother; 1999 Apr; 43(4):978-80. PubMed ID: 10103216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a cellulose acetate phthalate topical cream on vaginal transmission of simian immunodeficiency virus in rhesus monkeys.
    Manson KH; Wyand MS; Miller C; Neurath AR
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3199-202. PubMed ID: 11036053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Hydroxyphthaloyl beta-lactoglobulin. IV Antiviral activity in the mouse model of genital herpesvirus infection.
    Kokuba H; Aurelian L; Neurath AR
    Antivir Chem Chemother; 1998 Jul; 9(4):353-7. PubMed ID: 9875414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bovine beta-lactoglobulin modified by 3-hydroxyphthalic anhydride blocks the CD4 cell receptor for HIV.
    Neurath AR; Jiang S; Strick N; Lin K; Li YY; Debnath AK
    Nat Med; 1996 Feb; 2(2):230-4. PubMed ID: 8574970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-Hydroxyphthaloyl beta-lactoglobulin. III. Antiviral activity against herpesviruses.
    Neurath AR; Strick N; Li YY
    Antivir Chem Chemother; 1998 Mar; 9(2):177-84. PubMed ID: 9875389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor.
    Veazey RS; Ketas TJ; Dufour J; Moroney-Rasmussen T; Green LC; Klasse PJ; Moore JP
    J Infect Dis; 2010 Sep; 202(5):739-44. PubMed ID: 20629537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical nonnucleoside reverse transcriptase inhibitor MC 1220 partially prevents vaginal RT-SHIV infection of macaques.
    Stolte-Leeb N; Loddo R; Antimisiaris S; Schultheiss T; Sauermann U; Franz M; Mourtas S; Parsy C; Storer R; La Colla P; Stahl-Hennig C
    AIDS Res Hum Retroviruses; 2011 Sep; 27(9):933-43. PubMed ID: 21332419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239.
    Miller CJ; McChesney MB; Lü X; Dailey PJ; Chutkowski C; Lu D; Brosio P; Roberts B; Lu Y
    J Virol; 1997 Mar; 71(3):1911-21. PubMed ID: 9032322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of contraceptives containing nonoxynol-9 on the genital transmission of simian immunodeficiency virus in rhesus macaques.
    Miller CJ; Alexander NJ; Gettie A; Hendrickx AG; Marx PA
    Fertil Steril; 1992 May; 57(5):1126-8. PubMed ID: 1315297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Complement-Mediated Lysis of Simian Immunodeficiency Virus (SIV) and SIV-Infected Cells Reveals Sex Differences in Vaccine-Induced Immune Responses in Rhesus Macaques.
    Miller-Novak LK; Das J; Musich TA; Demberg T; Weiner JA; Venzon DJ; Mohanram V; Vargas-Inchaustegui DA; Tuero I; Ackerman ME; Alter G; Robert-Guroff M
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma interferon-mediated inflammation is associated with lack of protection from intravaginal simian immunodeficiency virus SIVmac239 challenge in simian-human immunodeficiency virus 89.6-immunized rhesus macaques.
    Abel K; La Franco-Scheuch L; Rourke T; Ma ZM; De Silva V; Fallert B; Beckett L; Reinhart TA; Miller CJ
    J Virol; 2004 Jan; 78(2):841-54. PubMed ID: 14694116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5.
    Lederman MM; Veazey RS; Offord R; Mosier DE; Dufour J; Mefford M; Piatak M; Lifson JD; Salkowitz JR; Rodriguez B; Blauvelt A; Hartley O
    Science; 2004 Oct; 306(5695):485-7. PubMed ID: 15486300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occult systemic infection and persistent simian immunodeficiency virus (SIV)-specific CD4(+)-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV.
    McChesney MB; Collins JR; Lu D; Lu X; Torten J; Ashley RL; Cloyd MW; Miller CJ
    J Virol; 1998 Dec; 72(12):10029-35. PubMed ID: 9811741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection.
    Veazey RS; Klasse PJ; Ketas TJ; Reeves JD; Piatak M; Kunstman K; Kuhmann SE; Marx PA; Lifson JD; Dufour J; Mefford M; Pandrea I; Wolinsky SM; Doms RW; DeMartino JA; Siciliano SJ; Lyons K; Springer MS; Moore JP
    J Exp Med; 2003 Nov; 198(10):1551-62. PubMed ID: 14623909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells.
    Quinnan GV; Yu XF; Lewis MG; Zhang PF; Sutter G; Silvera P; Dong M; Choudhary A; Sarkis PT; Bouma P; Zhang Z; Montefiori DC; Vancott TC; Broder CC
    J Virol; 2005 Mar; 79(6):3358-69. PubMed ID: 15731230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The immunological manifestations and cytological characteristics of infection caused by the simian immunodeficiency virus (SIV) in rhesus monkeys].
    Persidskiĭ IuV; Shcherbinskaia AM; Barshteĭn IuA; Antonenko SV; Marichev IL
    Tsitol Genet; 1993; 27(6):97-104. PubMed ID: 8066812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection.
    Van Rompay KK; Berardi CJ; Dillard-Telm S; Tarara RP; Canfield DR; Valverde CR; Montefiori DC; Cole KS; Montelaro RC; Miller CJ; Marthas ML
    J Infect Dis; 1998 May; 177(5):1247-59. PubMed ID: 9593009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies.
    Mascola JR; Stiegler G; VanCott TC; Katinger H; Carpenter CB; Hanson CE; Beary H; Hayes D; Frankel SS; Birx DL; Lewis MG
    Nat Med; 2000 Feb; 6(2):207-10. PubMed ID: 10655111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
    J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.
    Veazey RS; Klasse PJ; Schader SM; Hu Q; Ketas TJ; Lu M; Marx PA; Dufour J; Colonno RJ; Shattock RJ; Springer MS; Moore JP
    Nature; 2005 Nov; 438(7064):99-102. PubMed ID: 16258536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.